What is new in melanoma after European Cancer Congress 2017?

Melanoma Manag. 2017 May;4(2):83-87. doi: 10.2217/mmt-2017-0004. Epub 2017 May 15.

Author

Piotr Rutkowski¹

Affiliation

¹ Department of Soft Tissue/Bone Sarcoma & Melanoma, Maria Sklodowska-Curie Institute - Oncology Center, Roentgena 5, 02-781 Warsaw, Poland.

No abstract available

Keywords: BRAF inhibitor; MEK inhibitor; adjuvant; anti-CTLA-4; anti-PD-1; immunotherapy; melanoma; metastases; neoadjuvant.

Publication types

Editorial